ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag stock market genetics genomics evolution immunology

Artist’s rendering of various orange and pink colored bacteria
Q&A: What if Immune Cells Don’t Actually Detect Viruses and Bacteria?
Dan Robitzski | Feb 3, 2023 | 10+ min read
The Scientist spoke with Jonathan Kagan about his idea that immune cells respond to “errors” made by unsuccessful pathogens, not the pathogens themselves.
Once Promising Proteomics Market Sags
Susan Warner | Apr 14, 2002 | 6 min read
The once white-hot investment climate for proteomics has cooled, sending companies scrambling to recast themselves. Biotech analysts and investors say interest in proteomics companies peaked about a year ago with a rash of them competing in the technology and database sectors. In Europe, proteomics companies have also experienced a downturn, with biotech stocks falling 40% from their peak in 2000. Developing a new generation of technology and digitally mapping the proteome was, relatively speaki
The Genome Project Holds Promise, But We Must Look Before We Leap
Joshua Lederberg | Mar 19, 1989 | 3 min read
To an ever-increasing degree, explanation in biology is reduced to art expression in the language of DNA sequences. At least, a necessary condition for the interpretation of many problems in evolution, genetics, virology, immunology teratology, or cancer is the elucidation of a message in the well-known ATGC alphabet. Furthermore, the power of biotechnology rests on manufacturing blueprints of the same ilk. To a degree " unprecedented in biological history, we can describe the agenda for much
The Pangenome: Are Single Reference Genomes Dead?
Catherine Offord | Dec 1, 2016 | 10+ min read
Researchers are abandoning the concept of a list of genes sequenced from a single individual, instead aiming for a way to describe all the genetic variation within a species.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Week in Review: October 26–30
Tracy Vence | Oct 29, 2015 | 3 min read
Negative citations; cardiac stem cell saga continues; identifying anonymized genomic study participants; evolution of allergens; a call for biodefense innovation
Top 10 Innovations 2013
The Scientist | Dec 1, 2013 | 10+ min read
The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.
2020 end of year roundup science news wildfire pandemic coronavirus covid-19 salivary glands tubarial mitochondria in blood neanderthal dna in african genome first blood test for alzheimer's inclusivity black in x stem
The Biggest Science News of 2020
Kerry Grens | Dec 23, 2020 | 6 min read
Neanderthal DNA surprises in modern humans, the first blood test for Alzheimer’s, a discovery of new human salivary glands, and, oh yeah, a pandemic
Going Viral
Breeann Kirby and Jeremy J. Barr | Sep 1, 2013 | 10+ min read
From therapeutics to gene transfer, bacteriophages offer a sustainable and powerful method of controlling microbes.
Of Mice and Money
Alicia Ault(aault@the-scientist.com) | Jul 17, 2005 | 6 min read
James C. Foster, CEO of Charles River Laboratories, celebrated the company's five years of public trading by ringing the closing bell at the New York Stock Exchange on June 13.

Run a Search

ADVERTISEMENT